Fennec Pharmaceuticals (FENC) Net Equity Issued and Repurchased (2013 - 2020)

Fennec Pharmaceuticals (FENC) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $32.0 million in Q2 2020.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $32.0 million in Q2 2020, while the trailing twelve-month figure through Dec 2020 was $32.0 million (changed N/A YoY) and the FY2020 annual result came in at $32.0 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased improved to $32.0 million in Q2 2020, from -$1.1 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $32.0 million in Q2 2020 to a low of -$1.1 million in Q4 2018.
• A 4-year average of $5.8 million and a median of $383000.0 in 2017 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2017 — Net Equity Issued and Repurchased jumped 1533.33% — and 2018, when it sank 104.25%.
• Tracing FENC's Net Equity Issued and Repurchased over 4 years: stood at $4.9 million in 2016, then soared by 449.24% to $26.9 million in 2017, then slumped by 104.25% to -$1.1 million in 2018, then jumped by 2899.21% to $32.0 million in 2020.
• The last three Net Equity Issued and Repurchased figures came in at $32.0 million (Q2 2020), -$1.1 million (Q4 2018), and $483000.0 (Q3 2018), per Business Quant data.